NxR Biotechnologies (Nexar) is a consulting and investment firm assisting life science companies and academic institutions conducting business development or investment initiatives. Nexar provides services for performing strategic scientific and commercial assessments, technical writing, preparing business plans, gathering competitive intelligence, fund raising, and implementing partnerships and strategic alliances, divestitures, or commercialisation transactions.
Key focus areas include:
Nexar helps companies conduct due diligence regarding the scientific and business merits of biotechnological innovation, using a proven analysis metrics.
Key due diligence filters include:
Nexar conducts in the biotechnology arena divestitures and investments through implementing virtual teams. Linking key components to reach deep technology expertise and financial capabilities, Nexar builds upon its network of key opinion leaders and financial hourses to implement business and research projects in strategic or white space areas.
Key capabilities include:
Regenerative Medicine and Stem Cells
Industrial Biotechnology and Microbiology
Molecular Biology and Nucleic Acids (e.g., siRNA)
Nexar provides technical writing services in the biotechnology industry.
Key activities include:
NxR Biotechnologies GmbH, Andlauerhof, l'Atelier, Petersgasse 38, 4051 Basel, Swizerland
NxR Biotechnologies assists companies maximise project value by designing optimal strategies and implementing them through funding, partnering and marketing
NxR Biotechnologies GmbH © 2013-2015 | All Rights Reserved